Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Clin Cancer Res. 2022 Jul 1;28(13):2789–2795. doi: 10.1158/1078-0432.CCR-22-0162

Figure 2.

Figure 2.

PSA waterfall plot (phase Ib and II clinical studies) of patients treated with ≥ 63 mg daily. Bars labeled in green indicate patients (n = 4) that received 72 mg as their highest dose during the study.